Camilleri M, Mayer EA, Drossman DA, Heath AT, Dukes GE, McSorley DJ, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep;13(9):1149-59.
Schwartz HI, Perschy TB, McSorley DJ, Sorrells SC. Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. Am J Gastroenterol. 1999 Jun;4(2):121-7.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65. doi: 10.1016/S1081-1206(10)62606-3
Odom DM, Kalsbeek W. Further analysis of call history from the behavioral risk factor surveillance system. Poster presented at the Proceedings of the American Statistical Association, Section of Survey Research Methods; 1999. Alexandria, VA.
Lumry W, Windom H, Mendelson L, Pedinoff A, Prillaman B, Baitinger L, Woodring A, House K, Shah T. The salmeterol/fluticasone propionate (50/250 mcg) dry powder combination Diskus has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma. J Allergy Clin Immunol. 1999 Jan;103(1):S132.
Wolfe J, Bell T, Raphael G, Weinstein S, Baitinger L, Woodring A, Prillaman B, House K, Shah T. Efficacy of the salmeterol/fluticasone propionate dry powder combination product in the Diskus (R): a stratified study in patients on salmeterol alone or inhaled corticosteroids. J Allergy Clin Immunol. 1999 Jan;103(1):S228.